UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 12.

Harrer, A; Tumani, H; Niendorf, S; Lauda, F; Geis, C; Weishaupt, A; Kleinschnitz, C; Rauer, S; Kuhle, J; Stangel, M; Weber, F; Uhr, M; Linnebank, M; Wildemann, B; Jarius, S; Guger, M; Ayzenberg, I; Chan, A; Zettl, U; Wiendl, H; Pilz, G; Hitzl, W; Weber, J; Kraus, J (2013). Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Multiple Sclerosis Journal, 19(9):1209-1212.

Metz, I; Radue, E W; Oterino, A; Kümpfel, T; Wiendl, H; Schippling, S; Kuhle, J; Sahraian, M A; Gray, F; Jakl, V; Häusler, D; Brück, W (2012). Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathologica, 123(2):235-245.

Sobottka, B; Harrer, M D; Ziegler, U; Fischer, K; Wiendl, H; Hünig, T; Becher, B; Goebels, N (2009). Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss. American Journal of Pathology, 175(3):1160-1166.

Schreiner, B; Voss, J; Wischhusen, J; Dombrowski, Y; Steinle, A; Lochmüller, H; Dalakas, M; Melms, A; Wiendl, H (2006). Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB Journal, 20(1):118-120.

Schreiner, B; Kieseier, B C; Hartung, H P; Hohlfeld, R; Wiendl, H (2005). Blockade von Adhäsionsmolekülen mit Natalizumab in der Therapie der Multiplen Sklerose. Aktueller Studienstand. Der Nervenarzt, 76(8):999-1005.

Wiendl, H; Feger, U; Mittelbronn, M; Jack, C; Schreiner, B; Stadelmann, C; Antel, J; Brueck, W; Meyermann, R; Bar-Or, A; Kieseier, B C; Weller, M (2005). Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain: A Journal of Neurology, 128(Pt 11):2689-2704.

Magnus, T; Schreiner, B; Korn, T; Jack, C; Guo, H; Antel, J; Ifergan, I; Chen, L; Bischof, F; Bar-Or, A; Wiendl, H (2005). Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. Journal of Neuroscience, 25(10):2537-2546.

Mitsdoerffer, M; Schreiner, B; Kieseier, B C; Neuhaus, O; Dichgans, J; Hartung, H P; Weller, M; Wiendl, H (2005). Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Journal of Neuroimmunology, 159(1-2):155-164.

Schreiner, B; Mitsdoerffer, M; Kieseier, B C; Chen, L; Hartung, H P; Weller, M; Wiendl, H (2004). Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology, 155(1-2):172-182.

Weissert, R; Wiendl, H; Pfrommer, H; Storch, M K; Schreiner, B; Barth, S; Seifert, T; Melms, A; Dichgans, J; Weller, M (2003). Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes. Journal of Neuroimmunology, 144(1-2):28-37.

Wintterle, S; Schreiner, B; Mitsdoerffer, M; Schneider, D; Chen, L; Meyermann, R; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Research, 63(21):7462-7467.

Schreiner, B; Wischhusen, J; Mitsdoerffer, M; Schneider, D; Bornemann, A; Melms, A; Tolosa, E; Weller, M; Wiendl, H (2003). Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo. Glia, 44(3):296-301.

This list was generated on Sun Jul 23 07:23:51 2017 CEST.